HAWK and HARRIER: 96-Week outcomes from the phase 3 trials of brolucizumab for neovascular age-related macular degeneration
| Image |  |
|---|---|
| Description | scientific article published on 20 June 2020 |
| Author/s |
author: Ursula Schmidt-Erfurth |
| Publication date | June 20, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |